RT Journal Article
SR Electronic
T1 Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e008293
DO 10.1136/jitc-2023-008293
VO 12
IS 4
A1 Atkins, Michael B
A1 Jegede, Opeyemi A
A1 Haas, Naomi B
A1 Mcdermott, David F
A1 Bilen, Mehmet A
A1 Stein, Mark
A1 Sosman, Jeffrey
A1 Alter, Robert
A1 Plimack, Elizabeth R
A1 Ornstein, Moshe C
A1 Hurwitz, Michael
A1 Peace, David J
A1 Einstein, David
A1 Catalano, Paul J
A1 Hammers, Hans
A1 Regan, Meredith M
YR 2024
UL http://jitc.bmj.com/content/12/4/e008293.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.